Becker Muscular Dystrophy Market

Becker Muscular Dystrophy Market Research Report 2032

DelveInsight's "Becker Muscular Dystrophy Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Becker Muscular Dystrophy (BMD), historical and forecasted epidemiology as well as the Becker Muscular Dystrophy (BMD) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Becker Muscular Dystrophy (BMD) is an inherited muscle structure disorder that results in progressive deterioration of limbs, cardiac and skeletal muscles. However, the involuntary muscles are not affected. BMD is milder version of Duchenne Muscular Dystrophy (DMD). BMD usually begins in the teens or early adulthood, and the course is slower and far less predictable than that of DMD.

Some facts of Becker Muscular Dystrophy Market are:

· According to the Genetic and Rare Diseases Information Center, the prevalence of BMD is estimated to be between 17–27 cases per million people. This means that at a given time,about one in 37,000 to one in 59,000 people are living with BMD.

· According to the Centers for Disease Control and Prevention (CDC), the estimated prevalence of Duchenne and Becker muscular dystrophy (DBMD) was one in every 7,250 males aged 5–24 years. However, the prevalence of DMD was found to be three times higher than the prevalence of BMD.

· Through several studies, it can be estimated that the occurrence of BMD varies from one per 18,000 to one per 31,000 male births.

· According to a study conducted by Walter et al. titled “Recent developments in Duchenne muscular dystrophy: facts and numbers”, the worldwide prevalence of BMD is estimated to be 1.53 per 100,000 males and according to recent calculations of the German population, about 600 BMD patients are supposed to live in Germany.

Request for Sample Pages: https://www.delveinsight.com/report-store/becker-muscular-dystrophy-market

Scope of the Becker Muscular Dystrophy Market Report

· The report covers the descriptive overview of Becker Muscular Dystrophy (BMD), explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies

· Comprehensive insight has been provided into the Becker Muscular Dystrophy (BMD) epidemiology and treatment in the 7MM

· Additionally, an all-inclusive account of both the current and emerging therapies for Becker Muscular Dystrophy (BMD) is provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape

· A detailed review of the Becker Muscular Dystrophy (BMD) market; historical and forecasted is included in the report, covering drug outreach in the 7MM

· The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Becker Muscular Dystrophy (BMD) market

Some Becker Muscular Dystrophy Companies are:

· PTC Therapeutics

· Italfarmaco

· Epirium Bio

· Edgewise Therapeutics

· And Many Others

Request for Sample Pages: https://www.delveinsight.com/report-store/becker-muscular-dystrophy-market

Becker Muscular Dystrophy Drugs:

· Translarna

· Givinostat

· EPM-01

· EDG-5506

· And Many Others

Table of Content:

1. Key Insights

2. Executive Summary of Becker Muscular Dystrophy (BMD)

3. Competitive Intelligence Analysis for Becker Muscular Dystrophy (BMD)

4. Becker Muscular Dystrophy (BMD): Market Overview at a Glance

5. Becker Muscular Dystrophy (BMD): Disease Background and Overview

6. Patient Journey

7. Becker Muscular Dystrophy (BMD) Epidemiology and Patient Population

8. Treatment Algorithm, Current Treatment, and Medical Practices

9. Becker Muscular Dystrophy (BMD) Unmet Needs

10. Key Endpoints of Becker Muscular Dystrophy (BMD) Treatment

11. Becker Muscular Dystrophy (BMD) Marketed Products

12. Becker Muscular Dystrophy (BMD) Emerging Therapies

List to be continued in report

13. Becker Muscular Dystrophy (BMD): Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Market Outlook

16. Access and Reimbursement Overview of Becker Muscular Dystrophy (BMD)

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer